Next sale in the health insurance sector ?
🔹 Revenue: USD 48.74 billion (estimated USD 44.24 billion) ✅
🔹 Adjusted earnings per share: ( USD 0.16) (estimated USD 0.23) ❌
🔹 Health insurance ratio: 93.0% (estimated 91.6%) ❌ ; increase of +5.4 percentage points compared to the previous year
🔹 Total income from premiums and services: USD 42.47 billion; increase of 18% compared to the previous year
🔹 Selling and administrative expenses ratio: 7.1 %
Segment revenue:
🔹 Medicaid: USD 21.72 billion; increase of 7% compared to the previous year
Commercial: USD 10.07 billion; increase of 18% compared to the previous year
🔹 Medicare: USD 9.45 billion; increase of 58% compared to the previous year
🔹 Other: USD 1.22 billion; increase of 1% compared to the previous year
Other metrics
🔹 Cash flow from operating activities: USD 1.79 billion
🔹 Payability days for claims: 47 days
CEO comment:
➡️ "We are disappointed with our second quarter results, but have a clear understanding of the trends that impacted our performance and are working diligently and with focus to restore our earnings performance." - Sarah M. London
➡️ "Despite the changing landscape, we believe the staying power of Medicaid, Medicare and the Individual Marketplace is stronger than ever." - Sarah M. London
$UNH (+2.15%)
$US60855R1005 (+0.6%)
$CVS (-0.46%)
$CI (+0.27%)
$XDWH (+0.31%)
